31.01
price down icon9.43%   -3.25
 
loading
Schlusskurs vom Vortag:
$34.26
Offen:
$31.01
24-Stunden-Volumen:
542.72K
Relative Volume:
2.96
Marktkapitalisierung:
$442.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-3.21%
1M Leistung:
+38.90%
6M Leistung:
+82.85%
1J Leistung:
-32.65%
1-Tages-Spanne:
Value
$27.22
$31.48
1-Wochen-Bereich:
Value
$27.22
$35.47
52-Wochen-Spanne:
Value
$6.875
$74.49

Neurogene Inc Stock (NGNE) Company Profile

Name
Firmenname
Neurogene Inc
Name
Telefon
(877) 237-5020
Name
Adresse
535 W 24TH STREET, NEW YORK
Name
Mitarbeiter
107
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
NGNE's Discussions on Twitter

Vergleichen Sie NGNE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NGNE
Neurogene Inc
31.02 488.96M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.23 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
641.92 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
432.67 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
825.18 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.14 40.44B 447.02M -1.18B -868.57M -6.1812

Neurogene Inc Stock (NGNE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-17 Eingeleitet Craig Hallum Buy
2025-05-16 Herabstufung Robert W. Baird Outperform → Neutral
2024-06-27 Eingeleitet BMO Capital Markets Outperform
2024-06-11 Eingeleitet Robert W. Baird Outperform
2024-04-29 Eingeleitet Leerink Partners Outperform
2024-03-21 Eingeleitet William Blair Outperform
2024-01-08 Eingeleitet H.C. Wainwright Buy
2024-01-05 Eingeleitet Stifel Buy
2024-01-04 Eingeleitet TD Cowen Outperform
Alle ansehen

Neurogene Inc Aktie (NGNE) Neueste Nachrichten

pulisher
09:19 AM

Is Neurogene Inc. stock a buy on dipsWeekly Earnings Recap & Safe Entry Momentum Tips - newser.com

09:19 AM
pulisher
09:02 AM

Why Neurogene Inc. (UU8) stock could be top winnerQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com

09:02 AM
pulisher
08:35 AM

Tools to monitor Neurogene Inc. recovery probabilityTrade Exit Summary & Consistent Growth Stock Picks - newser.com

08:35 AM
pulisher
08:15 AM

Applying big data sentiment scoring on Neurogene Inc.2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com

08:15 AM
pulisher
07:46 AM

Is Neurogene Inc. (UU8) stock among top earnings playsDip Buying & Safe Swing Trade Setups - newser.com

07:46 AM
pulisher
07:45 AM

How to use a screener to detect Neurogene Inc. breakoutsMarket Movement Recap & Fast Entry and Exit Trade Plans - newser.com

07:45 AM
pulisher
07:06 AM

Using AI based signals to follow Neurogene Inc.Trade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com

07:06 AM
pulisher
06:42 AM

Can Neurogene Inc. (UU8) stock sustain institutional flowsQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com

06:42 AM
pulisher
06:33 AM

Will Neurogene Inc. (UU8) stock profit from automation waveJuly 2025 Pullbacks & Proven Capital Preservation Tips - newser.com

06:33 AM
pulisher
06:19 AM

Why Neurogene Inc. stock could outperform in 2025July 2025 Recap & High Conviction Buy Zone Picks - newser.com

06:19 AM
pulisher
05:58 AM

Will Neurogene Inc. stock outperform growth indexesEarnings Growth Summary & Verified Momentum Watchlists - newser.com

05:58 AM
pulisher
03:13 AM

Why Neurogene Inc. stock is popular among millennialsEarnings Trend Report & Weekly Breakout Watchlists - newser.com

03:13 AM
pulisher
03:08 AM

Why Neurogene Inc. stock remains a top recommendationWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com

03:08 AM
pulisher
01:45 AM

Signal strength of Neurogene Inc. stock in tech scanners2025 Volume Leaders & Free Verified High Yield Trade Plans - newser.com

01:45 AM
pulisher
01:38 AM

Risk adjusted return profile for Neurogene Inc. analyzedEntry Point & Long-Term Capital Growth Strategies - newser.com

01:38 AM
pulisher
12:45 PM

Does Neurogene Inc. qualify in momentum factor screeningBond Market & AI Based Buy/Sell Signal Reports - newser.com

12:45 PM
pulisher
12:09 PM

Why Neurogene Inc. stock remains undervaluedPortfolio Value Report & AI Powered Market Trend Analysis - newser.com

12:09 PM
pulisher
Nov 02, 2025

Is Neurogene Inc. (UU8) stock supported by strong fundamentalsGlobal Markets & Stepwise Trade Execution Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Will Neurogene Inc. (UU8) stock keep high P E multiplesPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Neurogene Inc. (UU8) stock a buy before new product rollout - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Price action breakdown for Neurogene Inc.July 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why Neurogene Inc. (UU8) stock could break out in 20252025 Trading Recap & Daily Profit Maximizing Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Combining price and volume data for Neurogene Inc.July 2025 Closing Moves & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Neurogene Inc. $NGNE Shares Bought by Jennison Associates LLC - MarketBeat

Nov 02, 2025
pulisher
Oct 31, 2025

HC Wainwright & Co. Maintains Neurogene (NGNE) Buy Recommendation - Nasdaq

Oct 31, 2025

Finanzdaten der Neurogene Inc-Aktie (NGNE)

Es liegen keine Finanzdaten für Neurogene Inc (NGNE) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.52
price down icon 0.26%
$28.69
price up icon 0.17%
$101.01
price up icon 8.01%
$104.29
price up icon 0.38%
biotechnology ONC
$312.00
price up icon 0.54%
$185.85
price down icon 1.79%
Kapitalisierung:     |  Volumen (24h):